Salicin inhirits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis

Salicin inhirits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis
复制标题

DOI:
10.1080/21691401.2019.1591427
复制
发表时间:
2019-01-01
影响因子:
5.8
通讯作者:
Zhang, Shanyong
Zhang, Shanyong
中科院分区:
工程技术2区
文献类型:
--
作者:
Gao, Feng;Zhang, Shanyong

文献摘要

被引文献

相似文献

骨关节炎(OA)是一种主要的年龄相关性疾病,可能与晚期糖基化终产物(AGEs)的积累有关。AGEs诱导的基质金属蛋白酶(MMPs)和具有血小板反应蛋白1型基序的去整合素和金属蛋白酶(ADAMTS)过度降解II型胶原和聚集蛋白聚糖是骨关节炎发病机制中的关键事件。此外,核因子-κ B(NF-κ B)通路的激活诱导促炎细胞因子级联的表达,如白细胞介素(IL)-1 β和肿瘤坏死因子-α(TNF-α)。在本研究中,我们研究水杨苷,阿司匹林的主要成分之一,八角枫的衍生物,对AGE诱导的SW 1353人软骨细胞的关节细胞外基质的降解的影响。我们的研究结果揭示了水杨苷在挽救II型胶原蛋白和聚集蛋白聚糖的降解、减少氧化应激、减弱促炎细胞因子的表达和抑制AGEs刺激的软骨细胞中NF-κ B促炎信号通路的激活方面的新的有益作用。因此,水杨苷可能成为一种安全有效的治疗OA发展和进展的药物。
Osteoarthritis (OA) is a major age-related disease, which may be caused by the accumulation of advanced glycation end-products (AGEs). Excessive degradation of type II collagen and aggrecan by matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS) induced by AGEs is a pivotal event in the pathogenesis of osteoarthritis. In addition, activation of the nuclear factor-kappa B (NF-kappa B) pathway induces the expression of a cascade of proinflammatory cytokines, such as interleukin (IL)-1 beta and tumor necrosis factor-alpha (TNF-alpha). In the present study, we investigated the effects of salicin, one of the main constituents of aspirin and a derivative of Alangium chinense, on AGE-induced degradation of the articular extracellular matrix in SW1353 human chondrocytes. Our findings reveal a novel beneficial role of salicin in rescuing degradation of type II collagen and aggrecan, reducing oxidative stress, attenuating expression of proinflammatory cytokines, and inhibiting activation of the NF-kappa B proinflammatory signaling pathway in chondrocytes stimulated with AGEs. Salicin may thus have potential as a safe and effective therapy against the development and progression of OA.